| MR编号 | DE/H/2754/001 |
|---|
| 药品名称 | Imipenem/Cilastatin Strides 250 mg/250 mg |
|---|
| 活性成分 | - cilastatin sodium salt 250.33 mg
- imipenem monohydrate 265.05 mg
|
|---|
| 剂型 | Powder for solution for infusion |
|---|
| 上市许可持有人 | Strides Arcolab International Limited
UNIT 4, Metro Centre, Tolpits Lane,
Watford, Hertfordshire, WD 189 SS
United Kingdom |
|---|
| 参考成员国 - 产品名称 | Germany (DE) Imipenem/Cilastatin Agila 250 mg/250 mg Pulver zur Herstellung einer Infusionslösung |
|---|
| 互认成员国 - 产品名称 | - Austria (AT)
- Bulgaria (BG)
Imipenem/Cilastatin Strides - Czechia (CZ)
Imipenem/Cilastatin STRIDES 250 mg/250 mg - Estonia (EE)
- Spain (ES)
- France (FR)
- Finland (FI)
- Hungary (HU)
Imipenem/Cilastatin STRIDES 250/250 mg por oldatos infúzióhoz - Italy (IT)
- Lithuania (LT)
Imipenem/Cilastatin STRIDES 250 mg/250 mg milteliai infuziniam tirpalui - Latvia (LV)
- Norway (NO)
- Poland (PL)
- Romania (RO)
Imipenem/ Cilastatin Strides 250 mg/ 250 mg pulbere pentru solutie perfuzabila - Sweden (SE)
- Slovakia (SK)
Imipenem/Cilastatin STRIDES 250 mg/250 mg - United Kingdom (GB)
|
|---|
| 许可日期 | 2014/03/19 |
|---|
| 最近更新日期 | 2014/07/09 |
|---|
| 药物ATC编码 | |
|---|